Download the Materials

Our Business

Discover TOHO HOLDINGS

Discover TOHO HOLDINGS

Our Business TOP

Pharmaceutical Wholesaling Business

Pharmaceutical Wholesaling Business
Dispensing Pharmacy Business

Dispensing Pharmacy Business

Pharmaceutical Manufacturing and Sales Business

Pharmaceutical Manufacturing and Sales Business

Others

Others

Corporate Information

Corporate Information TOP

Investor Relations

TOHO HOLDINGS at a Glance

TOHO HOLDINGS at a Glance

Investor Relations TOP

Sustainability

Sustainability TOP

 

Sustainability

Compliance

Compliance Policy

The Group has established the Compliance Promotion Regulations to ensure that officers and employees of the Group (including full-time employees, career staff, permanent and special contract employees, seconded personnel, contract workers, and part-time staff) comply with laws and regulations, respect social norms, conduct corporate activities with fairness, transparency, and a high sense of ethics, as well as to ensure management that fulfills its social responsibilities. We are committed to conducting our activities based on laws and ethics. To this end, we have established a “Code of Conduct” and annual goals, collectively known as our Compliance Program, which we continuously strive to implement.

Compliance Committee

The Company has established the Compliance Committee to ensure fair and sound business practices, driving and overseeing compliance across the entire Group.

Main Roles

The Compliance Committee deliberates and decides on the following matters, regularly reporting on its activities and the status of the whistle-blowing system, etc., to the Board of Directors, ensuring proper oversight by the Board.

  • Establishing basic compliance policies and regulations
  • Review of compliance progress
  • Compliance awareness activities and training

Compliance with Important Related Laws

Compliance with laws and regulations forms the basis of our business activities. Kyoso Mirai Group complies not only with important laws and regulations such as the Pharmaceutical and Medical Devices Act, the Pharmacists Act, the Antimonopoly Act, and the Act on Unjustifiable Premiums and Misleading Representations, but also with all laws and regulations related to its business activities. The Group also not only engages in activities based on laws and ethics but also always reviews its behaviors modestly to conduct business activities by giving openness, impartiality and the trust of society first priority.

Compliance with Important Related Laws

1. Compliance with the Act on Pharmaceuticals and Medical Devices

We will conduct business activities in compliance with laws and regulations

We will comply with laws and regulations such as the Act on Pharmaceuticals and Medical Devices, Narcotics and Psychotropics Control Act, and the Health Insurance Act, and properly conduct licensing, notification, reporting, and other procedures which are required based on laws and regulations.

  1. We will comply with the Act on Pharmaceuticals and Medical Devices and related laws and regulations to ensure the quality of pharmaceuticals.

  2. We will accurately understand potential purchasers (confirmation of required notification and permission) specified in the Act on Pharmaceuticals and Medical Devices to conduct appropriate sales.

  3. When handling pharmaceuticals, etc., we will take thorough measures against accidents such as theft, loss, and misplacement.

  4. If there is a risk of a violation of the Act on Pharmaceuticals and Medical Devices, we will promptly report to the person in charge of the business site and the supervising pharmacist, and if necessary, we will notify the relevant authorities to prevent a recurrence.

2. Compliance with the Pharmacists Act

We will protect people's health

On the basis of the principles of respecting life and maintaining individual dignity, we will build a trusting relationship with people, and provide quality and appropriate services in a courteous manner. In addition, we will coordinate a supply that respects the social security system in cooperation with other facilities providing medical services.

  1. If there is a dispensing request, we will not refuse it without a justifiable reason.

  2. We will fully inform patients.

  3. We will strive to reduce the risks of medical treatment by demonstrating our pharmacist occupational abilities.

  4. We will do our best in cooperation with other medical professionals.

  5. We will devote our life to self-improvement as a pharmacist.

3. Compliance with the Antimonopoly Act

We will engage in fair trading

We will properly understand the relevant laws and regulations and conduct sound and fair trading based on free competition. In addition, we will fully understand the National Public Service Ethics Act, the ethics rules of each local government, and the rules established by business partners, and will not engage in any act that violates or is suspected of violating these acts or rules.

  1. At meetings of trade associations, etc., if there is an act that is likely to violate the Antimonopoly Act, we will immediately express our opposition, report to the Company, and will not conduct any improper trading or arrangement.

  2. We will not receive improper entertainment or hospitality from our business partners and will not engage in such acts.

  3. We will not engage in gift-giving and entertainment for government employees (including parties legally regarded as public employees), and will resolutely refuse illegal requests for money, etc.

  4. We will not engage in transactions involving conflicts of interest and will not engage in transactions that may be suspected of conflicts of interest.

4. Compliance with the Act on Unjustifiable Premiums and Misleading Representations (the Fair Competition Code for Prescription Pharmaceutical Wholesaling)

We will comply with voluntary industry regulations

We will comply with the Fair Competition Code, which is a voluntary industry regulation based on the law which specifically stipulates "what is good and what is bad" regarding the provision of premiums, and will strive to create an environment in which ordinary consumers can choose better products and services safely.

  1. We will not make descriptions that are misleading regarding the quality, content or price of products or services.

  2. We will always check whether or not the premiums we intend to offer are excessive or may unreasonably induce transactions.

  3. We will maintain good faith and fair business relationships with all business partners and will not provide personal / arbitrary benefits and conveniences and labor, etc. whose provision is prohibited.

Establishment of a Whistleblowing Hotline

The Group has established a whistleblowing system for anyone to report or seek advice on potential legal or regulatory violations. This system is accessible to all our personnel, including current and former employees (full-time, contract, part-time, etc.), as well as to the personnel of our contractors. To ensure accessibility, in addition to telephone and email, we have set up the "TOHO Hotline" on our company intranet and also provide an external reporting desk managed by a third party.
This system is in place to broadly accept reports and consultations regarding violations of laws and internal regulations, human rights abuses such as harassment, and aim to prevent misconduct, ensure early detection, and implement corrective measures. By allowing anonymous access, we are committed to building an environment where anyone can feel secure in using the reporting and consultation channels without fear of retaliation. In addition, our internal rules clearly prohibit any attempt to identify whistleblowers or those seeking consultation, as well as any disadvantageous treatment based on their reporting or consultation.

Our whistleblowing system

  • Eligibility: The hotline is available for use by our current employees, former employees and the personnel of our contractors.
  • Confidentiality: Personal information related to the reporter and the content of the report will be used solely for the purposes of fact-finding, investigation, and taking corrective action.
  • Good Faith Reporting: We will investigate all reports properly and respond with integrity. However, this does not apply to reports that are knowingly false, intended to slander others, or made for any improper purpose.
  • Anonymous Reporting: Anonymous reports are also accepted. However, please understand that in such cases, there may be limitations to the investigation, and we will be unable to provide you with feedback on the results or preventive measures.

Internal Contact

E-mail: toho-compl@so.tohoyk.co.jp
Contact: Compliance Promotion Department, TOHO HOLDINGS

External Contact

A lawyer's office has been established as a contact point to ensure fairness and anonymity for whistleblowers.

Anti-corruption Initiatives

The Group has established the Anti-Bribery and Corrupt Practices Regulations that apply to its officers and employees (employees, career staff, temporary employees, special temporary employees, loaned employees, contract employees, part-time employees).
In accordance with laws and regulations related to the prevention of bribery and corruption that apply to officers and employees, public officials, and medical personnel, as well as industry codes such as the Fair Competition Code for Prescription Pharmaceutical Wholesaling, we are working to prevent bribery and corruption by prohibiting the provision of grants, donations, political donations, and other funds, and by establishing regulations on the provision of benefits such as money, gifts, services, entertainment, and food and drink.

Conducting compliance training

The Group conducts Group Compliance Training for officers and employees of the Company (employees, career staff, temporary employees, special temporary employees, loaned employees, contract employees, part-time employees) to raise the awareness of compliance among all Group employees. In addition to revising the training system from time to time, the Company issues the “Compla Kawaraban” twice a month to further promote understanding of knowledge and develop empathy.
The training covers a wide range of topics, including the Antimonopoly Act, the Fair Competition Code for the Ethical Pharmaceutical Wholesaling Industry, pharmaceutical-related laws and regulations, sales and promotional activities, the whistleblowing system, information security, human rights, and the prevention of bribery and other forms of corruption.

Elimination of antisocial forces

We will not engage in any special transactions with antisocial forces that threaten social order or safety, nor will we comply with any unreasonable demands, such as for money, made by antisocial forces. The Company has established the following response policy and is working to ensure that all employees are fully aware of it.

Response policy

  1. Responding as an organization

    We will respond to antisocial forces as an organization.

  2. Strengthening cooperation with external specialized organizations

    We will build close cooperative relationships with external specialized organizations, such as the police and the Center for Removal of Criminal Organizations, and actively participate in local efforts to eliminate organized crime groups.

  3. Cutting off all relations, including business transactions

    We will cut off all relations with antisocial forces, including business transactions.

  4. Civil and criminal legal responses in emergencies

    We will take legal action against unjust demands made by antisocial forces through both civil and criminal channels.

  5. Prohibition of all under-the-table deals and financial support

    We will not engage in any under-the-table deals with antisocial forces, nor will we provide them with any financial support.

Sustainability